瑞和數智(03680.HK)擬折讓18.65%配售最多1.3億股 淨籌3860萬港元
格隆匯5月2日丨瑞和數智(03680.HK)公告,於2025年5月2日,公司與配售代理訂立配售協議,據此,公司有條件同意委聘配售代理按盡力基準配售最多1.3億股配售股份予不少於六名承配人,而該等承配人及其最終實益擁有人均爲獨立第三方,每股配售股份價格爲港幣0.301元。
每股配售股份的配售價格爲0.301港元,相較於最後交易日在聯交所所報每股0.370港元的收市價,約有18.65%折讓;最多配售股份數目相當於截至本公告日期公司現有已發行股本約19.67%;倘配售協議項下配售股份悉數獲配售,則配售所得總款項預期約爲3910萬港元,扣除傭金及其他配售開支後,所得淨款項約爲3860萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.